Mond Harry G, Whitlock Ralph M L
Department of Medicine, University of Melbourne, Melbourne, Vic., Australia.
Heart Lung Circ. 2004 Jun;13(2):145-9. doi: 10.1016/j.hlc.2004.01.029.
A pacemaker (PM) and implantable cardioverter-defibrillator (ICD) survey was undertaken in Australia (Au) and New Zealand (NZ) for calendar year 2001.
Compared to the 1997 survey, significant increases in implantation numbers were recorded. For 2001, the total new PMs implanted was 9498 Au (6405 in 1997) and 914 NZ (823 in 1997). The number of new PM implants per million population was 486 Au (345 in 1997) and 245 NZ (228 in 1997). There were also significant increases in PM replacements between surveys with 1536 in Au (735 in 1997) and 195 in NZ (126 in 1997). Dual chamber implants were 71% Au (65% in 1997) and 56% NZ (55% in 1997). Pacing leads were overwhelmingly transvenous and bipolar with an increase in the use of active fixation leads in preference to tined leads, particularly in the atrium. There was a marked increase in the use of ICDs. The implants were 956 Au (449 in 1997) and 86 NZ (31 in 1997) with new implants per million population being 49 Au and 23 NZ. A breakdown of data for the six Au States and well as comparisons of similar surveys from other countries is presented.
对2001历年在澳大利亚（Au）和新西兰（NZ）进行了起搏器（PM）和植入式心脏复律除颤器（ICD）调查。
与1997年的调查相比，植入数量有显著增加。2001年，澳大利亚新植入的PM总数为9498例（1997年为6405例），新西兰为914例（1997年为823例）。每百万人口中新植入PM的数量，澳大利亚为486例（1997年为345例），新西兰为245例（1997年为228例）。两次调查之间PM更换数量也有显著增加，澳大利亚为1536例（1997年为735例），新西兰为195例（1997年为126例）。双腔植入比例，澳大利亚为71%（1997年为65%），新西兰为56%（1997年为55%）。起搏导线绝大多数为经静脉和双极型，与有倒刺导线相比，主动固定导线的使用有所增加，尤其是在心房。ICD的使用有显著增加。植入数量，澳大利亚为956例（1997年为449例），新西兰为86例（1997年为31例），每百万人口中新植入数量，澳大利亚为49例，新西兰为23例。给出了澳大利亚六个州的数据细分以及与其他国家类似调查的比较。
